AVTR logo

Avantor (AVTR) Stock

Profile

Full Name:

Avantor, Inc.

Sector:

Healthcare

Country:

United States

IPO:

17 May 2019

Indexes:

Not included

Description:

Avantor, Inc. is an American company specializing in the production of materials and equipment for the biopharmaceutical and healthcare industries. It has a history dating back to 1904 and was officially registered in its current form in 2017 in the state of Delaware. The portfolio of products and services includes: - Materials and consumables, including chemicals and reagents, laboratory products and consumables, specialized silicone materials, customized excipients, individual disposable assemblies, and more. - Equipment and instruments, such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low temperature freezers, biological safety cabinets, and materials for critical environments. - Services and specialized procurement, including laboratory and manufacturing services, procurement services, as well as services for the development of biopharmaceutical materials.

Key Details

Price

$21.95

Annual Revenue

$6.97 B(-7.26% YoY)

Annual EPS

$0.47(-53.47% YoY)

PE Ratio

48.78(-2.22% YoY)

Beta

0.73

Events Calendar

Earnings

Next earnings date:

Feb 07, 2025

Recent quarterly earnings:

Oct 25, 2024

Recent annual earnings:

Feb 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

21 Jan '25 Raymond James
Outperform
17 Jan '25 UBS
Neutral
28 Oct '24 Wells Fargo
Overweight
28 Oct '24 Baird
Outperform
25 Oct '24 Barclays
Overweight
08 Oct '24 UBS
Buy
26 Sept '24 RBC Capital
Outperform
27 Aug '24 Wells Fargo
Overweight
29 July '24 TD Cowen
Buy
29 July '24 Stifel
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
Avantor® to Report Fourth Quarter and Full Year 2024 Earnings on Friday, February 7, 2025
AVTR
prnewswire.com10 January 2025

Avantor, Inc. (NYSE: AVTR), a top global supplier of essential products and services for the life sciences and advanced technology sectors, has announced that it will share its financial results for the fourth quarter and full year of 2024 before the market opens on Friday, February 7. A conference call to discuss these results will take place on the same day at 8:00 a.m.

Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Avantor® to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
AVTR
prnewswire.com03 January 2025

RADNOR, Pa., Jan. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a top global supplier of essential products and services for the life sciences and advanced technology sectors, has announced that Michael Stubblefield, the President and CEO, will speak at the 43rd Annual J.P.

MD vs. AVTR: Which Stock Should Value Investors Buy Now?
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
AVTR
zacks.com27 December 2024

Investors interested in Medical Services stocks may have come across Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). However, which of these companies is the better choice for those seeking undervalued stocks?

Strong Earnings Report Lifted Avantor (AVTR) in Q3
Strong Earnings Report Lifted Avantor (AVTR) in Q3
Strong Earnings Report Lifted Avantor (AVTR) in Q3
AVTR
Insider Monkey19 December 2024

Sound Shore Management, an investment management company, has published its investor letter for the third quarter of 2024. You can download the letter here. In this quarter, the fund's Investor Class (SSHFX) and Institutional Class (SSHVX) saw increases of 6.70% and 6.74%, respectively, which is better than the 5.89% return of the Standard & Poor’s 500.

Avantor: Durable FCF Generator Trading For Cheap
Avantor: Durable FCF Generator Trading For Cheap
Avantor: Durable FCF Generator Trading For Cheap
AVTR
seekingalpha.com18 December 2024

Avantor has a strong business model that provides steady cash flow and keeps customers loyal. Its leading position in the biopharma sector and changing revenue sources can lead to significant profit growth. The company’s ability to generate substantial free cash flow can enhance its financial stability and benefit shareholders.

MD or AVTR: Which Is the Better Value Stock Right Now?
MD or AVTR: Which Is the Better Value Stock Right Now?
MD or AVTR: Which Is the Better Value Stock Right Now?
AVTR
zacks.com11 December 2024

Investors interested in Medical Services stocks may have come across Pediatrix Medical Group (MD) and Avantor, Inc. (AVTR). However, which of these two companies is the better choice for those seeking undervalued stocks?

Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Avantor® to Participate in the 7th Annual Evercore ISI HealthCONx Conference
AVTR
prnewswire.com20 November 2024

Avantor, Inc. (NYSE: AVTR), a top global supplier of essential products and services for the life sciences and advanced technology sectors, has announced that its President and CEO, Michael Stubblefield, will take part in a fireside chat at the Evercore ISI HealthCONx Conference. This event will be held in Coral Gables, Florida, on Tuesday, December 3, at 9:10 a.m.

Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing™ Technology
AVTR
businesswire.com20 November 2024

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI), known as The Protein Sequencing Company™, has revealed a distribution deal with Avantor® (NYSE: AVTR), a top provider of essential products and services for life sciences and advanced technology. This partnership will allow Avantor to distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) products, benefiting researchers in various fields.

MD vs. AVTR: Which Stock Is the Better Value Option?
MD vs. AVTR: Which Stock Is the Better Value Option?
MD vs. AVTR: Which Stock Is the Better Value Option?
AVTR
zacks.com07 November 2024

Investors interested in the Medical Services sector may want to look at Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). However, which of these companies is the better choice for those seeking undervalued stocks?

Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
AVTR
zacks.com28 October 2024

Even though AVTR remains stable in the Education and Advanced Technology sectors, it has reported a weaker performance in the third quarter.

FAQ

  • What is the primary business of Avantor?
  • What is the ticker symbol for Avantor?
  • Does Avantor pay dividends?
  • What sector is Avantor in?
  • What industry is Avantor in?
  • What country is Avantor based in?
  • When did Avantor go public?
  • Is Avantor in the S&P 500?
  • Is Avantor in the NASDAQ 100?
  • Is Avantor in the Dow Jones?
  • When was Avantor's last earnings report?
  • When does Avantor report earnings?
  • Should I buy Avantor stock now?

What is the primary business of Avantor?

Avantor, Inc. is an American company specializing in the production of materials and equipment for the biopharmaceutical and healthcare industries. It has a history dating back to 1904 and was officially registered in its current form in 2017 in the state of Delaware. The portfolio of products and services includes: - Materials and consumables, including chemicals and reagents, laboratory products and consumables, specialized silicone materials, customized excipients, individual disposable assemblies, and more. - Equipment and instruments, such as filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low temperature freezers, biological safety cabinets, and materials for critical environments. - Services and specialized procurement, including laboratory and manufacturing services, procurement services, as well as services for the development of biopharmaceutical materials.

What is the ticker symbol for Avantor?

The ticker symbol for Avantor is NYSE:AVTR

Does Avantor pay dividends?

No, Avantor does not pay dividends

What sector is Avantor in?

Avantor is in the Healthcare sector

What industry is Avantor in?

Avantor is in the Medical Instruments & Supplies industry

What country is Avantor based in?

Avantor is headquartered in United States

When did Avantor go public?

Avantor's initial public offering (IPO) was on 17 May 2019

Is Avantor in the S&P 500?

No, Avantor is not included in the S&P 500 index

Is Avantor in the NASDAQ 100?

No, Avantor is not included in the NASDAQ 100 index

Is Avantor in the Dow Jones?

No, Avantor is not included in the Dow Jones index

When was Avantor's last earnings report?

Avantor's most recent earnings report was on 25 October 2024

When does Avantor report earnings?

The next expected earnings date for Avantor is 7 February 2025

Should I buy Avantor stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions